Page last updated: 2024-09-02

perindopril and Hyperlipemia

perindopril has been researched along with Hyperlipemia in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (40.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (20.00)	2.80

Authors

Authors	Studies
Abo-Youssef, AM; Ali, MRA; Khattab, MM; Messiha, BAS	1
De la Figuera von Wichmann, M; Llisterri Caro, JL	1
Cohen, R; Emonnot, L; Lo, M	1
Krone, W; Middeke, M	1
Overlack, A; Stumpe, KO	1

Reviews

1 review(s) available for perindopril and Hyperlipemia

Article	Year
[Overview of cardiovascular risk factors]. Medicina clinica, 2006, Nov-25, Volume: 127, Issue:20 Topics: Age Factors; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Aspirin; Calcium Channel Blockers; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Male; Meta-Analysis as Topic; Perindopril; Platelet Aggregation Inhibitors; Primary Prevention; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Sex Factors; Smoking Prevention; Spain; Vasodilator Agents	2006

Article

Year

[Overview of cardiovascular risk factors].

Medicina clinica, 2006, Nov-25, Volume: 127, Issue:20

Topics: Age Factors; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Aspirin; Calcium Channel Blockers; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Male; Meta-Analysis as Topic; Perindopril; Platelet Aggregation Inhibitors; Primary Prevention; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Sex Factors; Smoking Prevention; Spain; Vasodilator Agents

2006

Trials

2 trial(s) available for perindopril and Hyperlipemia

Article	Year
Effects of perindopril on serum lipids in hypertensive patients with hyperlipidemia. Journal of cardiovascular pharmacology, 1994, Volume: 23, Issue:4 Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Apolipoproteins; Cholesterol; Double-Blind Method; Female; Humans; Hyperlipidemias; Hypertension; Indoles; Lipids; Male; Middle Aged; Perindopril; Triglycerides	1994
A new trial of the efficacy, tolerability, and safety of angiotensin-converting enzyme inhibition in mild systemic hypertension with concomitant diseases and therapies. Perindopril Therapeutic Safety Study Group (PUTS). The American journal of cardiology, 1993, Jun-24, Volume: 71, Issue:17 Topics: Adult; Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hyperlipidemias; Hypertension; Indoles; Kidney Diseases; Male; Middle Aged; Perindopril; Proteinuria; Treatment Outcome	1993

Article

Year

Effects of perindopril on serum lipids in hypertensive patients with hyperlipidemia.

Journal of cardiovascular pharmacology, 1994, Volume: 23, Issue:4

Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Apolipoproteins; Cholesterol; Double-Blind Method; Female; Humans; Hyperlipidemias; Hypertension; Indoles; Lipids; Male; Middle Aged; Perindopril; Triglycerides

1994

A new trial of the efficacy, tolerability, and safety of angiotensin-converting enzyme inhibition in mild systemic hypertension with concomitant diseases and therapies. Perindopril Therapeutic Safety Study Group (PUTS).

The American journal of cardiology, 1993, Jun-24, Volume: 71, Issue:17

Topics: Adult; Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hyperlipidemias; Hypertension; Indoles; Kidney Diseases; Male; Middle Aged; Perindopril; Proteinuria; Treatment Outcome

1993

Other Studies

2 other study(ies) available for perindopril and Hyperlipemia

Article	Year
Perindopril ameliorates experimental Alzheimer's disease progression: role of amyloid β degradation, central estrogen receptor and hyperlipidemic-lipid raft signaling. Inflammopharmacology, 2020, Volume: 28, Issue:5 Topics: Alzheimer Disease; Amyloid beta-Peptides; Angiotensin-Converting Enzyme Inhibitors; Animals; Cognitive Dysfunction; Disease Models, Animal; Disease Progression; Female; Hyperlipidemias; Insulysin; Membrane Microdomains; Neprilysin; Perindopril; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Signal Transduction	2020
Renal and metabolic disorders depend on the renin-angiotensin system in Lyon hypertensive rats associated with diabetes. American journal of hypertension, 2008, Volume: 21, Issue:6 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Hyperlipidemias; Hypertension; Kidney Diseases; Male; Perindopril; Proteinuria; Rats; Renin-Angiotensin System	2008

Article

Year

Perindopril ameliorates experimental Alzheimer's disease progression: role of amyloid β degradation, central estrogen receptor and hyperlipidemic-lipid raft signaling.

Inflammopharmacology, 2020, Volume: 28, Issue:5

Topics: Alzheimer Disease; Amyloid beta-Peptides; Angiotensin-Converting Enzyme Inhibitors; Animals; Cognitive Dysfunction; Disease Models, Animal; Disease Progression; Female; Hyperlipidemias; Insulysin; Membrane Microdomains; Neprilysin; Perindopril; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Signal Transduction

2020

Renal and metabolic disorders depend on the renin-angiotensin system in Lyon hypertensive rats associated with diabetes.

American journal of hypertension, 2008, Volume: 21, Issue:6

Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Hyperlipidemias; Hypertension; Kidney Diseases; Male; Perindopril; Proteinuria; Rats; Renin-Angiotensin System

2008